Although the molecular mechanisms underlying MED28-mediated oncogenesis are unknown, previous studies have suggested that MED28 can increase cancer cell proliferation, and phenotypes that are related to the dysregulation of MED28 have been demonstrated in breast cancer cells [11,13,19,20]. The gene discussed is MED28; the disease is breast cancer.